Stefan Leucht

1999–2026 年に発表

277
論文数
51,967
被引用数
121
h 指数
255
i10 指数

被引用数

Stefan Leucht の年別被引用数1978 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 13 件2001 年: 被引用 16 件2002 年: 被引用 26 件2003 年: 被引用 36 件2004 年: 被引用 48 件2005 年: 被引用 83 件2006 年: 被引用 112 件2007 年: 被引用 134 件2008 年: 被引用 143 件2009 年: 被引用 171 件2010 年: 被引用 257 件2011 年: 被引用 286 件2012 年: 被引用 326 件2013 年: 被引用 322 件2014 年: 被引用 331 件2015 年: 被引用 310 件2016 年: 被引用 291 件2017 年: 被引用 392 件2018 年: 被引用 388 件2019 年: 被引用 1,500 件2020 年: 被引用 1,613 件2021 年: 被引用 1,545 件2022 年: 被引用 1,345 件2023 年: 被引用 1,030 件2024 年: 被引用 1,978 件2025 年: 被引用 920 件2026 年: 被引用 57 件1979〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,162 件、この内訳の 17.7%イギリス: 引用元論文 1,949 件、この内訳の 10.9%ドイツ: 引用元論文 1,382 件、この内訳の 7.8%中国: 引用元論文 1,156 件、この内訳の 6.5%カナダ: 引用元論文 1,042 件、この内訳の 5.8%オーストラリア: 引用元論文 878 件、この内訳の 4.9%イタリア: 引用元論文 813 件、この内訳の 4.6%オランダ: 引用元論文 628 件、この内訳の 3.5%スペイン: 引用元論文 597 件、この内訳の 3.3%スイス: 引用元論文 515 件、この内訳の 2.9%日本: 引用元論文 403 件、この内訳の 2.3%フランス: 引用元論文 402 件、この内訳の 2.3%
0%17.7%その他 27.5%

分野

  • Medicine57.3%
  • Neuroscience16.5%
  • Psychology9.6%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Health Professions2.5%
  • Pharmacology, Toxicology and Pharmaceutics2.1%
  • その他6.4%

トピック

  • Schizophrenia research and treatment13.6%
  • Treatment of Major Depression5%
  • Tryptophan and brain disorders4.9%
  • Bipolar Disorder and Treatment4.1%
  • Mental Health and Psychiatry2.5%
  • Functional Brain Connectivity Studies2.4%
  • その他67.5%

共著者

全論文

検索で開く
  1. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

    著者: , , , , , , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2018 被引用: 3,459

  2. Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis

    著者: , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 被引用: 1,744

  3. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

    著者: , , , - Schizophrenia Bulletin 2016 被引用: 744

  4. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    著者: , , , , , , , , , , , , , , - The Lancet 2013 被引用: 2,537

  5. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

    著者: , , , , , , , , , , , , - World Psychiatry 2011 被引用: 2,495

  6. Living systematic review: 1. Introduction—the why, what, when, and how

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriel Rada, Matthew K. Bagg, Arwel W. Jones, Philippe Ravaud, Catherine Boden, Lara A Kahale, Bernt Richter, Isabelle Boisvert, Homa Keshavarz, Rebecca Ryan, Linn Brandt, Stephanie A. Kolakowsky‐Hayner, Dina H. Salama, Alexandra Bražinová, Sumanth Kumbargere Nagraj, Georgia Salanti, Rachelle Buchbinder, Toby J Lasserson, Lina Santaguida, Chris Champion, Rebecca Lawrence, Nancy Santesso, Jackie Chandler, Zbigniew Leś, Holger J. Schünemann, Andreas Charidimou, Stefan Leucht, Ian Shemilt, Roger Chou, Nicola Low, Diana Sherifali, Rachel Churchill, Andrew I.R. Maas, Reed Siemieniuk, Maryse C. Cnossen, Harriet MacLehose, Mark Simmonds, Marie-Joëlle Cossi, Malcolm Macleod, Nicole Skoetz, Michel Jacques Counotte, Iain Marshall, Karla Soares‐Weiser, Samantha Craigie, Iain Marshall, Velandai Srikanth, Philipp Dahm, Nicole Martin, Katrina Sullivan, Alanna Danilkewich, Laura Martínez García, Anneliese Synnot, Kristen Danko, Chris Mavergames, Mark Taylor, Emma Donoghue, Lara Maxwell, Kris Thayer, Corinna Dressler, James H. McAuley, James Thomas, Cathy Egan, Steve McDonald, Roger Tritton, Julian Elliott, Joanne E. McKenzie, Guy Tsafnat, Sarah A. Elliott, Joerg J Meerpohl, Peter Tugwell ほか 44 名 - Journal of Clinical Epidemiology 2017 被引用: 671

  7. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , - The Lancet 2022 被引用: 216

  8. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 737

  9. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

    著者: , , , , , , , , , , , , - American Journal of Psychiatry 2017 被引用: 536

  10. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

    著者: , , , , , - The Lancet 2008 被引用: 1,916

  11. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

    著者: , , , , , - American Journal of Psychiatry 2019 被引用: 294

  12. Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development

    著者: , , , , , , , , , , , - The Lancet Psychiatry 2023 被引用: 137

  13. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 被引用: 351

  14. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

    著者: , , , , , , , , - Journal of Affective Disorders 2015 被引用: 393

  15. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

    著者: , , , , , , - The Lancet 2012 被引用: 923

  16. Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art

    著者: , , , , , , , , - Schizophrenia Research Cognition 2022 被引用: 161

  17. Living systematic reviews: 4. Living guideline recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Homa Keshavarz, Rebecca Ryan, Linn Brandt, Stephanie A. Kolakowsky‐Hayner, Dina H. Salama, Alexandra Bražinová, Sumanth Kumbargere Nagraj, Georgia Salanti, Rachelle Buchbinder, Toby J Lasserson, Lina Santaguida, Chris Champion, Rebecca Lawrence, Nancy Santesso, Jackie Chandler, Zbigniew Leś, Holger J. Schünemann, Andreas Charidimou, Stefan Leucht, Ian Shemilt, Roger Chou, Nicola Low, Diana Sherifali, Rachel Churchill, Andrew I.R. Maas, Reed Siemieniuk, Maryse C. Cnossen, Harriet MacLehose, Mark Simmonds, Marie-Joëlle Cossi, Malcolm Macleod, Nicole Skoetz, Michel Jacques Counotte, Iain Marshall, Karla Soares‐Weiser, Samantha Craigie, Iain Marshall, Velandai Srikanth, Philipp Dahm, Nicole Martin, Katrina Sullivan, Alanna Danilkewich, Laura Martínez García, Anneliese Synnot, Kristen Danko, Chris Mavergames, Mark Taylor, Emma Donoghue, Lara Maxwell, Kris Thayer, Corinna Dressler, James H. McAuley, James Thomas, Cathy Egan, Steve McDonald, Roger Tritton, Julian Elliott, Joanne E. McKenzie, Guy Tsafnat, Sarah A. Elliott, Joerg J Meerpohl, Peter Tugwell, Itziar Etxeandia‐Ikobaltzeta, Bronwen Merner, Alexis F. Turgeon, Robin Featherstone, Stefania Mondello, Tari Turner, Ruth Foxlee, Richard Morley ほか 36 名 - Journal of Clinical Epidemiology 2017 被引用: 339

  18. Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis

    著者: , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 被引用: 317

  19. Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

    著者: , , , , , , , , - Translational Psychiatry 2021 被引用: 169

  20. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , - The Lancet Psychiatry 2021 被引用: 265

  21. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

    著者: , , , , , - Schizophrenia Bulletin 2014 被引用: 374

  22. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

    著者: , , , , , , , , , , , , , , , , - JAMA Psychiatry 2022 被引用: 124

  23. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis

    著者: , , , , - The Lancet Psychiatry 2023 被引用: 98

  24. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

    著者: , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2022 被引用: 208